C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 207/34 (2006.01) A61K 31/395 (2006.01) A61K 31/40 (2006.01) A61K 31/4164 (2006.01) A61K 31/435 (2006.01) C07D 233/90 (2006.01) C07D 401/04 (2006.01) C07D 405/04 (2006.01) C07D 405/12 (2006.01) C07D 409/12 (2006.01) C07D 521/00 (2006.01)
Patent
CA 2511859
The present invention relates to compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, m and X are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment . and/or prophylaxis of diseases which are associated with the modulation of CB 1 receptors.
L'invention concerne des composés de formule générale (I), dans laquelle R?1¿, R?2¿, R?3¿, R?4¿, R?5¿, R?6¿, m et X ont la signification indiquée dans la description et les revendications, et des sels acceptables sur le plan pharmaceutique de ceux-ci. Ces composés sont utiles pour le traitement et/ou la prophylaxie de maladies associées à la modulation des récepteurs CB1.
Marty Hans Peter
Mayweg Alexander
Mueller Werner
Narquizian Robert
Neidhart Werner
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Novel cb 1 receptor inverse agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel cb 1 receptor inverse agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel cb 1 receptor inverse agonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1374025